NASDAQ:DCGO

DocGo (DCGO) Stock Price, News & Analysis

DocGo logo
$0.17 0.00 (-2.22%)
Closing price 04:00 PM Eastern
Extended Trading
$0.18 +0.01 (+5.48%)
As of 05:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About DocGo Stock (NASDAQ:DCGO)

Advanced

Key Stats

Today's Range
$0.17
▼
$0.19
50-Day Range
$0.18
▼
$0.40
52-Week Range
$0.17
▼
$1.10
Volume
522,186 shs
Average Volume
851,619 shs
Market Capitalization
$16.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.50
Consensus Rating
Hold

Company Overview

DocGo Inc. is a healthcare services company that delivers medical care and patient transportation outside traditional healthcare facilities. Its services include mobile healthcare programs, in-home and community-based care, and ambulance transportation.

The company uses a technology platform to coordinate clinicians, emergency medical technicians and other healthcare professionals. Its mobile services support healthcare providers, government agencies and other organizations seeking to deliver care in homes and community settings.

DocGo traces its origins to Ambulnz, a medical transportation and mobile health company founded in 2015. It began trading as a public company in 2021 following a business combination with Motion Acquisition Corp. The company serves clients in the United States and the United Kingdom.

AI Generated. May Contain Errors.

DocGo Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
50th Percentile Overall Score

DCGO MarketRank™: 
2.52113444232 of 5 stars

DocGo scored higher than 50% of companies evaluated by MarketBeat, and ranked 997th out of 1,704 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    DocGo has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    DocGo has a consensus price target of $1.50, representing about 752.3% upside from its current price of $0.18.

  • Amount of Analyst Coverage

    DocGo has only been the subject of 2 research reports in the past 90 days.

  • Read more about DocGo's stock forecast and price target.
  • Earnings Growth

    Earnings for DocGo are expected to grow in the coming year, from ($0.25) to $0.01 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of DocGo is -0.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of DocGo is -0.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    DocGo has a P/B Ratio of 0.22. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.27% of the float of DocGo has been sold short.
  • Short Interest Ratio / Days to Cover

    DocGo has a short interest ratio ("days to cover") of 3.86, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in DocGo has recently increased by 7.87%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    DocGo does not currently pay a dividend.

  • Dividend Growth

    DocGo does not have a long track record of dividend growth.

  • News Sentiment

    DocGo has a news sentiment score of -0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.37 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for DocGo this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, DocGo insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    5.10% of the stock of DocGo is held by insiders.

  • Percentage Held by Institutions

    56.44% of the stock of DocGo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about DocGo's insider trading history.
Receive DCGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DocGo and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DCGO Stock News Headlines

DocGo (NASDAQ:DCGO) Stock Price Target Cut by Needham & Company LLC
The next convergence is here
In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This past May, flooding cut the supply route into the largest uranium complex on the planet, and in July Cigar Lake went down a second time. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.tc pixel
DocGo (DCGO) Q3 2026 Earnings Call Transcript
DocGo Inc. (DCGO) Q3 2026 Earnings Call Transcript
DocGo Inc. (DCGO) Stock Falls on Q3 2026 Earnings
DocGo (DCGO) Expected to Release Quarterly Earnings on Monday
See More Headlines

DCGO Stock Analysis - Frequently Asked Questions

DocGo's stock was trading at $0.8778 at the beginning of the year. Since then, DCGO stock has decreased by 79.9% and is now trading at $0.1760.

DocGo Inc. (NASDAQ:DCGO) announced its quarterly earnings results on Monday, November, 9th. The company reported ($0.17) earnings per share for the quarter, missing analysts' consensus estimates of ($0.11) by $0.06. The firm earned $73.43 million during the quarter, compared to analysts' expectations of $76.96 million. DocGo had a negative trailing twelve-month return on equity of 63.66% and a negative net margin of 60.96%.
Read the conference call transcript
.

DocGo's top institutional investors include State Street Corp (0.41%), Empowered Funds LLC (0.10%), Ieq Capital LLC (0.08%) and Goldman Sachs Group Inc. (0.07%). Insiders that own company stock include Lee Bienstock, Michael J Burdiek, Stephen Sugrue, Ely D Tendler and Stephen K MD Klasko.
View institutional ownership trends
.

Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that DocGo investors own include NVIDIA (NVDA), Palantir Technologies (PLTR), Alibaba Group (BABA), IonQ (IONQ), Occidental Petroleum (OXY), Pfizer (PFE) and AT&T (T).

Company Calendar

Last Earnings
11/09/2026
Today
11/19/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:DCGO
CIK
1822359
Fax
N/A
Employees
3,568
Year Founded
N/A

Price Target and Rating

High Price Target
$2.50
Low Price Target
$1.00
Potential Upside/Downside
+774.1%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.85)
Trailing P/E Ratio
N/A
Forward P/E Ratio
17.16
P/E Growth
N/A
Net Income
-$182.40 million
Net Margins
-60.96%
Pretax Margin
-55.30%
Return on Equity
-63.66%
Return on Assets
-33.31%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.38
Quick Ratio
1.38

Sales & Book Value

Annual Sales
$297.34 million
Price / Sales
0.06
Cash Flow
$0.05 per share
Price / Cash Flow
3.31
Book Value
$0.80 per share
Price / Book
0.21

Miscellaneous

Outstanding Shares
98,992,000
Free Float
93,943,000
Market Cap
$16.99 million
Optionable
Optionable
Beta
1.03
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (NASDAQ:DCGO) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners